Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Pulmonary Hypertension, February 2024 Free Subscription Abstracts Retrieve all available abstracts of the following 171 articles: HTML format

Single Articles

1. ZHU F, de Oliveira CB, Mohsen N, Kharrat A, et al
   Challenges in clinical identification of right ventricular dysfunction in preterm infants with persistent pulmonary hypertension of the newborn.
   Early Hum Dev. 2024;190:105942.
   PubMed    
   Abstract available
   
   

2. EKICI M, Ileri S, Unaldi E, Bayram GSK, et al
   Are Behcet's disease patients with Budd-Chiari at increased risk for the development of pulmonary hypertension?
   Rheumatology (Oxford). 2024 Feb 1:keae067. doi: 10.1093.
   PubMed    
   
   
   

3. DU P, Gao X, Sun Q, Gong M, et al
   Association between uric acid and cardiac outcomes mediated by neutrophil-to-lymphocyte ratio in patients with left ventricular diastolic dysfunction and pulmonary hypertension.
   Sci Rep. 2024;14:2751.
   PubMed    
   Abstract available
   
   

4. HANG C, Zu L, Luo X, Wang Y, et al
   Ddx5 Targeted Epigenetic Modification of Pericytes in Pulmonary Hypertension Following Intrauterine Growth Restriction.
   Am J Respir Cell Mol Biol. 2024 Feb 1. doi: 10.1165/rcmb.2023-0244.
   PubMed    
   Abstract available
   
   

5. VETEL K, Eyries M, Savale L, Kanengiesser C, et al
   Pulmonary Veno-Occlusive Disease and Pulmonary Fibrosis in a Family with EIF2AK4 Pathogenic Variants.
   Am J Respir Cell Mol Biol. 2024;70:143-145.
   PubMed    
   
   
   

6. EL KABBOUT R, Azhar N, Breuils-Bonnet S, Martineau S, et al
   Time Is Running Out in Pulmonary Arterial Hypertension: The Epigenetic Clock Is Clicking.
   Am J Respir Cell Mol Biol. 2024;70:140-143.
   PubMed    
   
   
   

7. ARSLAN A, Smith J, Qureshi MR, Uysal A, et al
   Evolution of pulmonary hypertension in interstitial lung disease: a journey through past, present, and future.
   Front Med (Lausanne). 2024;10:1306032.
   PubMed    
   Abstract available
   
   

8. STOKES G, Li Z, Talaba N, Genthe W, et al
   Rescuing lung development through embryonic inhibition of histone acetylation.
   Sci Transl Med. 2024;16:eadc8930.
   PubMed    
   Abstract available
   
   

9. KHAN S, Randhawa S, Patail H, Spira Y, et al
   Pharmacological Update and Emerging Treatments of Pulmonary Hypertension.
   Cardiol Rev. 2024 Jan 31. doi: 10.1097/CRD.0000000000000647.
   PubMed    
   Abstract available
   
   

10. 
    Correction to: Discrimination Between Pre- and Postcapillary Pulmonary Hypertension Using Platelet RNA.
    J Am Heart Assoc. 2024 Jan 31:e027751. doi: 10.1161/JAHA.122.027751.
    PubMed    
    
    
    

11. SILVA J, Carvoeiro A, Cerqueira P, Calheiros A, et al
    Reversible Pulmonary Hypertension Related to Hyperthyroidism: A Case Report.
    Cureus. 2023;15:e51377.
    PubMed    
    Abstract available
    
    

12. ZHANG J, Li Q, Liao P, Xiao R, et al
    Calcium sensing receptor: A promising therapeutic target in pulmonary hypertension.
    Life Sci. 2024;340:122472.
    PubMed    
    Abstract available
    
    

13. PORT SC
    Is there a role for nuclear cardiology in pulmonary hypertension?
    J Nucl Cardiol. 2024;31:101776.
    PubMed    
    
    
    

14. PARIKH R, Thomas A, Sharofi A, Moallem N, et al
    Severe pulmonary hypertension-interstitial lung disease presenting as right ventricular failure: stabilisation with intravenous prostacyclin and maintenance with inhaled prostacyclin.
    ERJ Open Res. 2024;10:00659-2023.
    PubMed    
    Abstract available
    
    

15. BUTERA G, Piccinelli E, Kolesnik A, Averin K, et al
    Implantation of atrial flow regulator devices in patients with congenital heart disease and children with severe pulmonary hypertension or cardiomyopathy-an international multicenter case series.
    Front Cardiovasc Med. 2024;10:1332395.
    PubMed    
    Abstract available
    
    

16. SUN T, Yuan W, Wei Y, Liao D, et al
    The Regulatory Role and Mechanism of Energy Metabolism in Vascular Diseases.
    Front Biosci (Landmark Ed). 2024;29:26.
    PubMed    
    Abstract available
    
    

17. YANG Y, Huang X, Lin J
    Anti-MDA5 antibody-associated clinically amyopathic dermatomyositis diagnosed after the onset of pulmonary hypertension.
    Int J Rheum Dis. 2024;27:e15027.
    PubMed    
    Abstract available
    
    

18. EMAMI MEYBODI M, Bamarinejad A, Bamarinejad F, Abhari AP, et al
    Prognostic Implication of Preprocedural Pulmonary Hypertension in Patients with Severe Aortic Valve Stenosis Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-analysis.
    Cardiol Rev. 2024 Jan 29. doi: 10.1097/CRD.0000000000000583.
    PubMed    
    Abstract available
    
    

19. SHI H, Gao P, Liu H, Su J, et al
    Diagnostic value of combined FVC%/DLCO% and echocardiography in connective tissue disorder?associated pulmonary hypertension.
    Med Int (Lond). 2024;4:8.
    PubMed    
    Abstract available
    
    

20. KIM YJ, Shin SH, Kim EK, Kim HS, et al
    Short term effect of intravenous treprostinil in term and preterm infants with pulmonary hypertension.
    BMC Pediatr. 2024;24:83.
    PubMed    
    Abstract available
    
    

21. MARTIN MV, Menchero AG, Ferreiro RG, Morist AA, et al
    Expert center and balloon pulmonary angioplasty network program in chronic thromboembolic pulmonary hypertension: safety and effectiveness of a pioneering experience.
    Rev Esp Cardiol (Engl Ed). 2024 Jan 25:S1885-5857(24)00034.
    PubMed    
    
    
    

22. GROSS CR, Varghese R, Zafirova Z
    Perioperative Management of Novel Pharmacotherapies for Heart Failure and Pulmonary Hypertension.
    Anesthesiol Clin. 2024;42:117-130.
    PubMed    
    Abstract available
    
    

23. NEVES DA SILVA HV, Weinman JP, Englund EK, Deterding RR, et al
    Computed tomographic findings in TBX4 mutation: a common cause of severe pulmonary artery hypertension in children.
    Pediatr Radiol. 2024 Jan 9. doi: 10.1007/s00247-023-05848.
    PubMed    
    Abstract available
    
    

24. MASOOD M, Singh P, Hariss D, Khan F, et al
    Nitric oxide as a double-edged sword in pulmonary viral infections: Mechanistic insights and potential therapeutic implications.
    Gene. 2024;899:148148.
    PubMed    
    Abstract available
    
    

25. AHMED HF, Guzman-Gomez A, Desai M, Dani A, et al
    Lung Transplantation for Pulmonary Vascular Disease in Children: A United Network for Organ Sharing Analysis.
    Pediatr Cardiol. 2024;45:385-393.
    PubMed    
    Abstract available
    
    

26. ROBINSON G, Zielstorff M, Sevilla R, Vanko A, et al
    Multimodal Imaging Reveals that Sustained Inhibition of HIF-Prolyl Hydroxylases Induces Opposing Effects on Right and Left Ventricular Function in Healthy Rats.
    Mol Imaging Biol. 2024;26:179-187.
    PubMed    
    Abstract available
    
    

27. LI H, Liu S, Dai W, Yao B, et al
    Pressure-sensitive multivesicular liposomes as a smart drug-delivery system for high-altitude pulmonary edema.
    J Control Release. 2024;365:301-316.
    PubMed    
    Abstract available
    
    

28. KUWAJIMA K, Ogawa M, Ruiz I, Yamane T, et al
    Comparison of prognostic value among echocardiographic surrogates of right ventricular-pulmonary arterial coupling: A three-dimensional echocardiographic study.
    Echocardiography. 2024;41:e15717.
    PubMed    
    Abstract available
    
    

29. BOUCETTA H, Zhang L, Sosnik A, He W, et al
    Pulmonary arterial hypertension nanotherapeutics: New pharmacological targets and drug delivery strategies.
    J Control Release. 2024;365:236-258.
    PubMed    
    Abstract available
    
    

30. GILLAM-KRAKAUER M, Reese J
    We Still Don't Know When to Close a Patent Ductus Arteriosus in Very Premature Infants.
    J Pediatr. 2023 Nov 3:113817. doi: 10.1016/j.jpeds.2023.113817.
    PubMed    
    
    
    

31. HUERTAS NIETO S, Velazquez Martin M, Sarnago Cebada F, Jimenez Lopez-Guarch C, et al
    Value of exercise right heart catheterization in the differential diagnosis of chronic thromboembolic pulmonary disease.
    Rev Esp Cardiol (Engl Ed). 2024;77:158-166.
    PubMed    
    Abstract available
    
    

32. BIEDERMANN P, Sitte-Koch V, Schweiger M, Meinold A, et al
    Pulmonary hemodynamics before and after pediatric heart transplantation.
    Clin Transplant. 2023 Oct 12:e15162. doi: 10.1111/ctr.15162.
    PubMed    
    Abstract available
    
    

33. ADLY G, Mithoefer O, Elliott Epps J, Hajj JM, et al
    Right Ventricular Contractility and Pulmonary Arterial Coupling After Less Invasive Left Ventricular Assist Device Implantation.
    ASAIO J. 2024;70:99-106.
    PubMed    
    Abstract available
    
    

34. SAINATHAN S, Ryan J, Mullinari L, Sanchez P, et al
    Lung transplantation in primary pulmonary arterial hypertension and pulmonary venous hypertension.
    Clin Transplant. 2024;38:e15158.
    PubMed    
    Abstract available
    
    

35. FAVERIO P, Paciocco G, Tassistro E, Rebora P, et al
    Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study.
    Intern Emerg Med. 2024;19:183-190.
    PubMed    
    Abstract available
    
    

36. HUANG J, An Q, Shi H, Li C, et al
    Retrospective cohort study of pulmonary arterial hypertension associated with connective tissue disease effect on patients' prognosis.
    Clin Rheumatol. 2023;42:3131-3142.
    PubMed    
    Abstract available
    
    

37. RANASINGHE ADCU, Tennakoon TMPB, Schwarz MA
    Emerging Epigenetic Targets and Their Molecular Impact on Vascular Remodeling in Pulmonary Hypertension.
    Cells. 2024;13:244.
    PubMed    
    Abstract available
    
    

38. ZHANG Y, Zhang M, Yang H, Li H, et al
    Serum proteome profiling reveals heparanase as a candidate biomarker for chronic thromboembolic pulmonary hypertension.
    iScience. 2024;27:108930.
    PubMed    
    Abstract available
    
    

39. MIN S, Wesselowski SR, Nabity MB, Yankin I, et al
    Pulmonary hypertension is associated with hypocoagulability in dogs: a retrospective analysis of 66 cases (2013-2021).
    Am J Vet Res. 2024 Feb 12:1-8. doi: 10.2460/ajvr.23.11.0252.
    PubMed    
    Abstract available
    
    

40. FUJII S, Nagayoshi S, Matsumoto T, Miyamoto T, et al
    Spontaneous hemodynamic improvement after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension is observed within a short term after balloon pulmonary angioplasty.
    Cardiovasc Interv Ther. 2024 Feb 8. doi: 10.1007/s12928-024-00987.
    PubMed    
    Abstract available
    
    

41. KANG Y, Jiang X
    Pregnancy outcomes and risk factors of serious cardiovascular adverse events in pregnant women with pulmonary hypertension.
    Int J Surg. 2024 Feb 8. doi: 10.1097/JS9.0000000000001016.
    PubMed    
    
    
    

42. GAO N, Lv Y, Cui Y, Wang P, et al
    Bosentan in the treatment of persistent pulmonary hypertension in newborns: a systematic review and meta-analysis.
    Cardiol Young. 2024 Feb 8:1-8. doi: 10.1017/S1047951123004456.
    PubMed    
    Abstract available
    
    

43. WILLEMS L, Kurakula K, Verhaegen J, Klok FA, et al
    Angiogenesis in Chronic Thromboembolic Pulmonary Hypertension: A Janus-Faced Player?
    Arterioscler Thromb Vasc Biol. 2024 Feb 8. doi: 10.1161/ATVBAHA.123.319852.
    PubMed    
    Abstract available
    
    

44. CHALERMPROMMA P, Surachetpong SD
    Indicators for pulmonary hypertension in dogs with degenerative mitral valve disease.
    Vet World. 2023;16:2515-2520.
    PubMed    
    Abstract available
    
    

45. QU SS, Li YL, Huang RR, Guo H, et al
    [Impact of hyperoxia on the phenotype of pulmonary artery smooth muscle cells].
    Zhonghua Xin Xue Guan Bing Za Zhi. 2024;52:185-190.
    PubMed    
    Abstract available
    
    

46. HUANG J, Li QY, Ji W, Guo XF, et al
    [Clinical and genetic analysis of a patient with HUPRA syndrome due to missense variants of SARS2 gene and literature review].
    Zhonghua Xin Xue Guan Bing Za Zhi. 2024;52:172-179.
    PubMed    
    Abstract available
    
    

47. JAIN L
    Pulmonary Hypertension of the Newborn.
    Clin Perinatol. 2024;51:xv-xvii.
    PubMed    
    
    
    

48. LAKSHMINRUSIMHA S, Abman SH
    Neonatal Pulmonary Hypertension: Phenotypes, Physiology, and Management.
    Clin Perinatol. 2024;51:xix-xxii.
    PubMed    
    
    
    

49. COOKSON MW, Kinsella JP
    Inhaled Nitric Oxide in Neonatal Pulmonary Hypertension.
    Clin Perinatol. 2024;51:95-111.
    PubMed    
    Abstract available
    
    

50. LAKSHMINRUSIMHA S, Abman SH
    Oxygen Targets in Neonatal Pulmonary Hypertension: Individualized, "Precision-Medicine" Approach.
    Clin Perinatol. 2024;51:77-94.
    PubMed    
    Abstract available
    
    

51. BOYD SM, Kluckow M, McNamara PJ
    Targeted Neonatal Echocardiography in the Management of Neonatal Pulmonary Hypertension.
    Clin Perinatol. 2024;51:45-76.
    PubMed    
    Abstract available
    
    

52. STIEREN ES, Sankaran D, Lakshminrusimha S, Rottkamp CA, et al
    Comorbidities and Late Outcomes in Neonatal Pulmonary Hypertension.
    Clin Perinatol. 2024;51:271-289.
    PubMed    
    Abstract available
    
    

53. COLETTI K, Wild KT, Foglia EE, Otter SC, et al
    Randomized Controlled Trials of Pulmonary Vasodilator Therapy Adjunctive to Inhaled Nitric Oxide for Persistent Pulmonary Hypertension of the Newborn: A Systematic Review.
    Clin Perinatol. 2024;51:253-269.
    PubMed    
    Abstract available
    
    

54. BANDIYA P, Madappa R, Joshi AR
    Etiology, Diagnosis and Management of Persistent Pulmonary Hypertension of the Newborn in Resource-limited Settings.
    Clin Perinatol. 2024;51:237-252.
    PubMed    
    Abstract available
    
    

55. DANHAIVE O, Galambos C, Lakshminrusimha S, Abman SH, et al
    Pulmonary Hypertension in Developmental Lung Diseases.
    Clin Perinatol. 2024;51:217-235.
    PubMed    
    Abstract available
    
    

56. YOUNG KC, Schmidt AF, Tan AW, Sbragia L, et al
    Pathogenesis and Physiologic Mechanisms of Neonatal Pulmonary Hypertension: Preclinical Studies.
    Clin Perinatol. 2024;51:21-43.
    PubMed    
    Abstract available
    
    

57. ABMAN SH, Lakshminrusimha S
    Pulmonary Hypertension in Established Bronchopulmonary Dysplasia: Physiologic Approaches to Clinical Care.
    Clin Perinatol. 2024;51:195-216.
    PubMed    
    Abstract available
    
    

58. MANI S, Mirza H, Ziegler J, Chandrasekharan P, et al
    Early Pulmonary Hypertension in Preterm Infants.
    Clin Perinatol. 2024;51:171-193.
    PubMed    
    Abstract available
    
    

59. MOORE SS, Keller RL, Altit G
    Congenital Diaphragmatic Hernia: Pulmonary Hypertension and Pulmonary Vascular Disease.
    Clin Perinatol. 2024;51:151-170.
    PubMed    
    Abstract available
    
    

60. GEISINGER R, Rios DR, McNamara PJ, Levy PT, et al
    Asphyxia, Therapeutic Hypothermia, and Pulmonary Hypertension.
    Clin Perinatol. 2024;51:127-149.
    PubMed    
    Abstract available
    
    

61. CARROLL J, Rao R, Steinhorn RH
    Targeted Therapies for Neonatal Pulmonary Hypertension: Beyond Nitric Oxide.
    Clin Perinatol. 2024;51:113-126.
    PubMed    
    Abstract available
    
    

62. NABESHIMA Y, Kitano T, Node K, Takeuchi M, et al
    Prognostic value of right ventricular free-wall longitudinal strain in patients with pulmonary hypertension: systematic review and meta-analyses.
    Open Heart. 2024;11:e002561.
    PubMed    
    Abstract available
    
    

63. CAGUANA-VELEZ OA, Khilzi K, Piccari L, Rodriguez-Sevilla JJ, et al
    Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism in SARS-CoV-2.
    Respiration. 2024 Feb 7:1-9. doi: 10.1159/000536064.
    PubMed    
    Abstract available
    
    

64. WANG J, Kuang J, Zhang S, Liu Z, et al
    Comprehensive characterization of small noncoding RNA profiles in hypoxia-induced pulmonary hypertension (HPH) rat tissues.
    iScience. 2024;27:108815.
    PubMed    
    Abstract available
    
    

65. ALKHATEEBALTAMIMI D, Khalidi K, Khasawneh R, Alzaben A, et al
    Recurrent Syncope Unveiling Pulmonary Hypertension Secondary to Pulmonary Artery Thrombi in a Pediatric Patient.
    Cureus. 2024;16:e51812.
    PubMed    
    Abstract available
    
    

66. GAYEN SK, Zulty M, Criner GJ
    Elevated pulmonary vascular resistance is associated with increased lung transplant waitlist mortality among patients with chronic obstructive pulmonary disease and pulmonary hypertension: a retrospective cohort analysis.
    Respir Res. 2024;25:79.
    PubMed    
    Abstract available
    
    

67. ANDERSON J, Grell R, Haines D
    Anaesthetic management of a patient with severe pulmonary hypertension, moderate tricuspid regurgitation and moderate right ventricular dysfunction presenting for a dilation and curettage.
    BMJ Case Rep. 2024;17:e257225.
    PubMed    
    Abstract available
    
    

68. DWIVEDI K, Sharkey M, Delaney L, Alabed S, et al
    Improving Prognostication in Pulmonary Hypertension Using AI-quantified Fibrosis and Radiologic Severity Scoring at Baseline CT.
    Radiology. 2024;310:e231718.
    PubMed    
    Abstract available
    
    

69. ZHENG H, Wu D, Chen X, He W, et al
    Endothelial downregulation of nuclear m6A reader YTHDC1 promotes pulmonary vascular remodeling in sugen hypoxia model of pulmonary hypertension.
    Heliyon. 2024;10:e24963.
    PubMed    
    Abstract available
    
    

70. AHMED S, Ahmed A, Radegran G
    Structured evaluation of unclear dyspnea-An attempt to shorten the diagnostic delay in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Pulm Circ. 2024;14:e12340.
    PubMed    
    
    
    

71. OSTASEVICIUS V, Jurenas V, Venslauskas M, Kizauskiene L, et al
    Low-frequency ultrasound for pulmonary hypertension therapy.
    Respir Res. 2024;25:70.
    PubMed    
    Abstract available
    
    

72. COMARITA IK, Tanko G, Anghelache IL, Georgescu A, et al
    The siRNA-mediated knockdown of AP-1 restores the function of the pulmonary artery and the right ventricle by reducing perivascular and interstitial fibrosis and key molecular players in cardiopulmonary disease.
    J Transl Med. 2024;22:137.
    PubMed    
    Abstract available
    
    

73. ZHANG J, Zhang Y, Yin Y, Feng Y, et al
    'Fear, uncertain, tired......' psychological distress among pulmonary hypertension patients: a qualitative interview study.
    BMC Psychiatry. 2024;24:100.
    PubMed    
    Abstract available
    
    

74. HINZE CA, Park DH, Bollmann BA
    Pulmonary Artery Aneurysm in Longstanding Idiopathic Pulmonary Arterial Hypertension.
    Dtsch Arztebl Int. 2023;120.
    PubMed    
    
    
    

75. BENSLIMANE Z, Yavuz S, Francis N
    A rare presentation of childhood interstitial lung disease attributed to KDM3B gene mutation: a case report.
    Pan Afr Med J. 2023;46:84.
    PubMed    
    Abstract available
    
    

76. BRANESCU I, Vladareanu S, Shetty S, Alexandru DO, et al
    Sildenafil in Pulmonary Hypertension Associated with Bronchopulmonary Dysplasia: Friend or Foe?
    Curr Health Sci J. 2023;49:319-324.
    PubMed    
    Abstract available
    
    

77. BATTA A, Hatwal J
    Development of pulmonary hypertension remains a major hurdle to corrective surgery in Down syndrome.
    World J Cardiol. 2024;16:1-4.
    PubMed    
    Abstract available
    
    

78. KASSA B, Fonseca-Balladares DC, Kumar R, Lee MH, et al
    Experimental Schistosoma haematobium pulmonary hypertension.
    Pulm Circ. 2024;14:e12336.
    PubMed    
    Abstract available
    
    

79. WANG W, Gong JN, Wang JF, Ding Y, et al
    [Hemodynamic changes with serial balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:120-125.
    PubMed    
    Abstract available
    
    

80. ANAND V, Weston AD, Scott CG, Kane GC, et al
    Machine Learning for Diagnosis of Pulmonary Hypertension by Echocardiography.
    Mayo Clin Proc. 2024;99:260-270.
    PubMed    
    Abstract available
    
    

81. JIANG G, Shi LF, Li LJ, Duan XJ, et al
    Activation of the p62-Keap1-Nrf2 pathway improves pulmonary arterial hypertension in MCT-induced rats by inhibiting autophagy.
    FASEB J. 2024;38:e23452.
    PubMed    
    Abstract available
    
    

82. LAN WF, Deng Y, Dai P, Wu DD, et al
    Right ventricular-pulmonary arterial coupling ratio derived from 3-dimensional echocardiography predicts outcomes in systemic lupus erythematosus-associated pulmonary arterial hypertension patients.
    Lupus. 2024;33:155-165.
    PubMed    
    Abstract available
    
    

83. LI MH, Liu X, Xie YL, Tang XG, et al
    Sodium butyrate alleviates right ventricular hypertrophy in pulmonary arterial hypertension by inhibiting H19 and affecting the activation of let-7g-5p/IGF1 receptor/ERK.
    Eur J Pharmacol. 2024 Jan 2:176315. doi: 10.1016/j.ejphar.2024.176315.
    PubMed    
    Abstract available
    
    

84. LU J, Alenezi F, Bier E, Leewiwatwong S, et al
    Optimized quantitative mapping of cardiopulmonary oscillations using hyperpolarized (129) Xe gas exchange MRI: Digital phantoms and clinical evaluation in CTEPH.
    Magn Reson Med. 2024;91:1541-1555.
    PubMed    
    Abstract available
    
    

85. LIU Q, Yang Y, Wu M, Wang M, et al
    Hub gene ELK3-mediated reprogramming lipid metabolism regulates phenotypic switching of pulmonary artery smooth muscle cells to develop pulmonary arterial hypertension induced by PM(2.5).
    J Hazard Mater. 2024;465:133190.
    PubMed    
    Abstract available
    
    

86. GRUNIG E, Rahaghi F, Elwing J, Vizza CD, et al
    Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension.
    Adv Ther. 2024;41:618-637.
    PubMed    
    Abstract available
    
    

87. KIM D, Choi KH, Kim H, Lee JH, et al
    Right lower lung midline herniation as a rare complication in an infant with heart-lung transplantation: A case report.
    Pediatr Transplant. 2024;28:e14656.
    PubMed    
    Abstract available
    
    

88. XANTHOULI P, Echampati I, Lorenz HM, Heussel CP, et al
    Respiratory involvement in connective tissue diseases.
    Eur J Intern Med. 2024;120:11-16.
    PubMed    
    Abstract available
    
    

89. REYES-HERNANDEZ ME, Bischoff AR, Giesinger RE, Rios DR, et al
    Echocardiography Assessment of Left Ventricular Function in Extremely Preterm Infants, Born at Less Than 28 Weeks' Gestation, With Bronchopulmonary Dysplasia and Systemic Hypertension.
    J Am Soc Echocardiogr. 2024;37:237-247.
    PubMed    
    Abstract available
    
    

90. KOPEC G, Araszkiewicz A, Magon W, Stepniewski J, et al
    Results of atrial flow regulator implantation in pulmonary arterial hypertension patients with severe heart failure despite maximal medical therapy.
    Kardiol Pol. 2024;82:75-78.
    PubMed    
    
    
    

91. SHI S, Zhu X, Cheang I, Liao S, et al
    Development and validation of a diagnostic nomogram in pulmonary hypertension due to left heart disease.
    Heart Lung. 2024;65:11-18.
    PubMed    
    Abstract available
    
    

92. MURAKAMI T, Ohno Y, Horinouchi H, Noda S, et al
    Vericiguat and transcatheter edge-to-edge mitral valve repair for combined post- and pre-capillary pulmonary hypertension due to left ventricular low ejection fraction and functional mitral regurgitation.
    J Cardiol Cases. 2023;29:78-81.
    PubMed    
    Abstract available
    
    

93. SHARMA S, Antoniak S
    New Insights in the Pathology of Chronic Thromboembolic Pulmonary Hypertension.
    JACC Basic Transl Sci. 2024;9:117-119.
    PubMed    
    
    
    

94. SMALL M, Perchenet L, Bennett A, Linder J, et al
    The diagnostic journey of pulmonary arterial hypertension patients: results from a multinational real-world survey.
    Ther Adv Respir Dis. 2024;18:17534666231218886.
    PubMed    
    Abstract available
    
    

95. DUENAS-MEZA E, Severiche-Bueno DF, Santos Quintero C, Talani Ochoa J, et al
    Prevalence of pulmonary hypertension in children with obstructive sleep apnea living at high altitude.
    Sleep Med X. 2024;7:100106.
    PubMed    
    Abstract available
    
    

96. ROSEN C, Jacqmart C, Charlier C, Beghetti M, et al
    [Risks of magistral preparations in pediatrics].
    Rev Med Liege. 2024;79:104-109.
    PubMed    
    Abstract available
    
    

97. GARRETT ME, Foster MW, Telen MJ, Ashley-Koch AE, et al
    Nontargeted Plasma Proteomic Analysis of Renal Disease and Pulmonary Hypertension in Patients with Sickle Cell Disease.
    J Proteome Res. 2024 Feb 14. doi: 10.1021/acs.jproteome.3c00748.
    PubMed    
    Abstract available
    
    

98. PEER SB, Loor G, Han JW, Shafii AE, et al
    Surgical right pulmonary artery to left atrial shunt for severe pulmonary hypertension and bridge to lung transplantation.
    JTCVS Tech. 2023;23:178-181.
    PubMed    
    
    
    

99. DEBOEVER N, Eapen GA, Casal RF, Durand JB, et al
    Endobronchial ultrasound: A novel screening test for pulmonary hypertension prior to major pulmonary surgery.
    JTCVS Tech. 2023;23:146-153.
    PubMed    
    Abstract available
    
    

100. YOSHIDA S, Eichelberger O, Ulis M, Kreger AM, et al
     Intra-Amniotic Sildenafil and Rosiglitazone Late in Gestation Ameliorate the Pulmonary Hypertension Phenotype in Congenital Diaphragmatic Hernia.
     J Pediatr Surg. 2024 Jan 23:S0022-3468(24)00017.
     PubMed    
     Abstract available
     
     

101. YIM IHW, Parker KH, Drury NE, Lim HS, et al
     Pulmonary artery wave intensity analysis in pulmonary hypertension associated with heart failure and reduced left ventricular ejection fraction.
     Pulm Circ. 2024;14:e12345.
     PubMed    
     Abstract available
     
     

102. ZHOU J, Guo D, Xu ZZ, Liao JS, et al
     Nupr1-mediated vascular smooth muscle cell phenotype transformation involved in methamphetamine induces pulmonary hypertension.
     Cell Biol Toxicol. 2024;40:13.
     PubMed    
     Abstract available
     
     

103. DEL VALLE KT, Krowka MJ, Schinstock CA, Nath KA, et al
     Hemodynamic response to inhaled nitric oxide in patients with pulmonary hypertension and chronic kidney disease: A retrospective cohort study.
     Pulm Circ. 2024;14:e12341.
     PubMed    
     Abstract available
     
     

104. BAILEY ME, Durst L, Cajigas HR, Kane GC, et al
     Using PAH-SYMPACT to assess quality of life in patients with pulmonary hypertension associated with chronic lung disease.
     Pulm Circ. 2024;14:e12343.
     PubMed    
     Abstract available
     
     

105. FAKHRY B, Peterson L, Comhair SAA, Sharp J, et al
     Blood Cholesterol and Triglycerides Associate with Right Ventricular Function in Pulmonary Hypertension.
     medRxiv. 2024 Jan 22:2024.01.20.24301498. doi: 10.1101/2024.01.20.24301498.
     PubMed    
     Abstract available
     
     

106. OWUSU IK, Amponsah GM, Wiafe YA
     Severe Pulmonary Hypertension From Combined Ventricular Septal Defect and Rheumatic MIitral Valve Disease: A Case Report and Literature Review.
     Clin Med Insights Case Rep. 2024;17:11795476241231140.
     PubMed    
     Abstract available
     
     

107. CUETO-ROBLEDO G, Cantero-Ceballos MD, Gonzalez-Hermosillo LM, Navarro-Vergara DI, et al
     Severe Pulmonary Hypertension in Pulmonary Alveolar Microlithiasis: A Comprehensive Literature Review.
     Curr Probl Cardiol. 2024 Feb 9:102453. doi: 10.1016/j.cpcardiol.2024.102453.
     PubMed    
     Abstract available
     
     

108. LEE J, Cho DH, Min HJ, Son YB, et al
     Higher sclerostin is associated with pulmonary hypertension in pre-dialysis end-stage kidney disease patients: a cross-sectional prospective observational cohort study.
     BMC Pulm Med. 2024;24:78.
     PubMed    
     Abstract available
     
     

109. INOUE K, Andersen OS, Remme EW, Khan FH, et al
     Echocardiographic Evaluation of Left Ventricular Filling Pressure in Patients With Pulmonary Hypertension.
     JACC Cardiovasc Imaging. 2024 Jan 28:S1936-878X(24)00024.
     PubMed    
     
     
     

110. VAIDY A, Vahdatpour CA, Mazurek J
     Exercise Testing in Patients with Pulmonary Hypertension.
     J Clin Med. 2024;13:795.
     PubMed    
     Abstract available
     
     

111. BIGDELU L, Alimi H, Fazlinezhad A, Ghaderi F, et al
     Novel echocardiographic parameters in pulmonary hypertension assessment and the relationship between echocardiography and 6-minute walking test.
     Medicine (Baltimore). 2024;103:e35294.
     PubMed    
     Abstract available
     
     

112. MOURA DE AZEVEDO S, Furtado I, Carvalho L, Reis A, et al
     10-year success story in CTEPH treatment: breaking the myth of rareness.
     BMJ Case Rep. 2024;17:e257942.
     PubMed    
     Abstract available
     
     

113. RAHIMI M, Rahimi S, Karimi Torshizi MA, Sharafi M, et al
     The effect of peroxisome proliferator-activated receptor gamma (PPARgamma) as a mediator of dietary fatty acids and thiazolidinedione in pulmonary arterial hypertension induced by cold stress of broilers.
     Res Vet Sci. 2024;168:105157.
     PubMed    
     Abstract available
     
     

114. KIM H, Liu Y, Kim J, Kim Y, et al
     Pericytes contribute to pulmonary vascular remodeling via HIF2alpha signaling.
     EMBO Rep. 2024;25:616-645.
     PubMed    
     Abstract available
     
     

115. HAN PL, Jiang L, Cheng JL, Shi K, et al
     Artificial intelligence-assisted diagnosis of congenital heart disease and associated pulmonary arterial hypertension from chest radiographs: A multi-reader multi-case study.
     Eur J Radiol. 2023;171:111277.
     PubMed    
     Abstract available
     
     

116. BOBROVSKI VG, Pinheiro AL, de-Castro JAL, Rech EB, et al
     Schistosomiasis: A neglected cause of pulmonary arterial hypertension in Brazil.
     Curr Probl Cardiol. 2024;49:102340.
     PubMed    
     Abstract available
     
     

117. BENINCASA G, Strozziero MG, Trama U, Napoli C, et al
     Unsolved Issues on Beneficial Effects of Combination Therapy With Sotatercept in Pulmonary Arterial Hypertension.
     Heart Lung Circ. 2024;33:12-13.
     PubMed    
     
     
     

118. KIPFMUELLER F, Leyens J, Pugnaloni F, Bo B, et al
     Spontaneous breathing in selected neonates with very mild congenital diaphragmatic hernia.
     Pediatr Pulmonol. 2023 Nov 29. doi: 10.1002/ppul.26791.
     PubMed    
     Abstract available
     
     

119. EDEL GG, Hol JA, Slot E, von der Thusen JH, et al
     Clinical Relevance of Rapid FOXF1-Targeted Sequencing in Patients Suspected of Alveolar Capillary Dysplasia With Misalignment of Pulmonary Veins.
     Lab Invest. 2023;103:100233.
     PubMed    
     Abstract available
     
     

120. OKNINSKA M, Zajda K, Zambrowska Z, Grzanka M, et al
     Role of Oxygen Starvation in Right Ventricular Decompensation and Failure in Pulmonary Arterial Hypertension.
     JACC Heart Fail. 2024;12:235-247.
     PubMed    
     Abstract available
     
     

121. OKUNUSHI K, Kobayashi H, Yoh Y, Kunimatsu M, et al
     A case report of a child with pulmonary hypertension associated with SARS-CoV-2 infection.
     Front Pediatr. 2024;12:1336589.
     PubMed    
     Abstract available
     
     

122. BOLLOVA D, Reptova A, Valkovicova T, Gazdikova K, et al
     Risk of chronic thromboembolic pulmonary hypertension after splenectomy.
     Bratisl Lek Listy. 2024;125:176-182.
     PubMed    
     Abstract available
     
     

123. SATO S, Ito T, Tabata T, Ogawa A, et al
     Corrigendum: Effect of balloon pulmonary angioplasty on cardio-ankle vascular index and biventricular remodeling in patients with chronic thromboembolic pulmonary hypertension.
     Front Cardiovasc Med. 2024;11:1377556.
     PubMed    
     Abstract available
     
     

124. KOPEC G, Forfia P, Abe K, Beaudet A, et al
     Recognition, diagnosis, and operability assessment of chronic thromboembolic pulmonary hypertension (CTEPH): A global cross-sectional scientific survey (CLARITY).
     Pulm Circ. 2024;14:e12330.
     PubMed    
     Abstract available
     
     

125. LIN P, Jiang F, Li X, Zhao Y, et al
     International trends in pulmonary hypertension mortality between 2001 and 2019: Retrospective analysis of the WHO mortality database.
     Heliyon. 2024;10:e26139.
     PubMed    
     Abstract available
     
     

126. MULLER J, Appenzeller P, Lichtblau M, Saxer S, et al
     Effects of 5-Week Oral Acetazolamide on Incremental Cycling Exercise in Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension: A Randomized Placebo-Controlled, Double-Blinded, Crossover Trial.
     Respiration. 2024 Feb 21:1-10. doi: 10.1159/000536399.
     PubMed    
     Abstract available
     
     

127. ONGEN HG, Akdeniz B, Duzenli MA, Chernyavsky A, et al
     Diagnosis and Treatment Patterns of Chronic Thromboembolic Pulmonary Hypertension in Russia, Kazakhstan, Turkey, Lebanon, and Saudi Arabia: A Registry Study.
     Drugs Real World Outcomes. 2024 Feb 21. doi: 10.1007/s40801-023-00407.
     PubMed    
     Abstract available
     
     

128. SHEN T, Shi J, Zhao X, Fu L, et al
     Presenilin 1 Is a Therapeutic Target in Pulmonary Hypertension and Promotes Vascular Remodeling.
     Am J Respir Cell Mol Biol. 2024 Feb 21. doi: 10.1165/rcmb.2022-0426.
     PubMed    
     Abstract available
     
     

129. ZHANG W, Li M, Ye X, Jiang M, et al
     Disturbance of mitochondrial dynamics in myocardium of broilers with pulmonary hypertension syndrome.
     Br Poult Sci. 2024 Feb 21:1-11. doi: 10.1080/00071668.2024.2308277.
     PubMed    
     Abstract available
     
     

130. MIAO H, Hui H, Fan W, Lin Y, et al
     Overexpressed pigment epithelium-derived factor alleviates pulmonary hypertension in two rat models induced by monocrotaline and SU5416/hypoxia.
     Biomed Pharmacother. 2024;172:116303.
     PubMed    
     Abstract available
     
     

131. LI K, Shen C, Wen N, Han Y, et al
     EPO regulates the differentiation and homing of bone marrow mesenchymal stem cells through Notch1/Jagged pathway to treat pulmonary hypertension.
     Heliyon. 2024;10:e25234.
     PubMed    
     Abstract available
     
     

132. MINAMITANI Y, Kato S, Hosokawa M, Nakashima T, et al
     Inhaled nitric oxide therapy for preterm infants after 7 days of age: a scoping review protocol.
     BMJ Open. 2024;14:e080298.
     PubMed    
     Abstract available
     
     

133. HOSKING M, Bates A
     Therapy in pediatric pulmonary hypertension: memoire of an unfinished journey.
     Can J Cardiol. 2024 Feb 17:S0828-282X(24)00173.
     PubMed    
     
     
     

134. FUJII S, Nagayoshi S, Miyamoto T, Ogawa K, et al
     The beneficial effects of balloon pulmonary angioplasty for patients with chronic thromboembolic pulmonary hypertension are accompanied by increased body mass index and improved nutritional status.
     Pulm Circ. 2024;14:e12347.
     PubMed    
     Abstract available
     
     

135. LIU B, Yi D, Li S, Ramirez K, et al
     Endothelial fatty acid-binding proteins contribute to the pathogenesis of pulmonary hypertension.
     bioRxiv [Preprint]. 2024 Feb 11:2024.02.11.579846.
     PubMed    
     Abstract available
     
     

136. DUARTE AC, Alegria S, Vinagre F, Ferreira F, et al
     Can subcutaneous treprostinil be an alternative for treating pulmonary hypertension in patients with systemic sclerosis-related interstitial lung disease?
     ARP Rheumatol. 2024.
     PubMed    
     Abstract available
     
     

137. KASHIWADA T, Tanaka Y, Tanaka T, Okano T, et al
     Clinical course of COPD patients with exercise-induced elevation of pulmonary artery pressure or less severe pulmonary hypertension presenting with respiratory symptoms and the impact of bosentan intervention-prospective, single-center, randomized, pa
     BMC Pulm Med. 2024;24:90.
     PubMed    
     Abstract available
     
     

138. DAI L, Chen Y, Wu J, He Z, et al
     A novel complement C3 inhibitor CP40-KK protects against experimental pulmonary arterial hypertension via an inflammasome NLRP3 associated pathway.
     J Transl Med. 2024;22:164.
     PubMed    
     Abstract available
     
     

139. TORBIC H, Tonelli AR
     Sotatercept for Pulmonary Arterial Hypertension in the Inpatient Setting.
     J Cardiovasc Pharmacol Ther. 2024;29:10742484231225310.
     PubMed    
     Abstract available
     
     

140. MULLER A, Escribano-Subias P, Fernandes CC, Fontana M, et al
     Real-World Management of Patients with Pulmonary Arterial Hypertension: Insights from EXPOSURE.
     Adv Ther. 2024;41:1103-1119.
     PubMed    
     Abstract available
     
     

141. BARBERA J, Jansa P, Klings E, Ristic A, et al
     Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension.
     Adv Ther. 2024;41:1062-1074.
     PubMed    
     Abstract available
     
     

142. LEWIS MI, Shapiro S, Oudiz RJ, Nakamura M, et al
     The ALPHA phase 1 study: pulmonary ArteriaL hypertension treated with CardiosPHere-Derived allogeneic stem cells.
     EBioMedicine. 2024;100:104900.
     PubMed    
     Abstract available
     
     

143. LIAO K, Mackenzie H, Ait-Oudhia S, Manimaran S, et al
     The Impact of Immunogenicity on the Pharmacokinetics, Efficacy, and Safety of Sotatercept in a Phase III Study of Pulmonary Arterial Hypertension.
     Clin Pharmacol Ther. 2024;115:478-487.
     PubMed    
     Abstract available
     
     

144. SCHONFELD T, Seitz P, Krieghoff C, Ponorac S, et al
     High-pitch CT pulmonary angiography (CTPA) with ultra-low contrast medium volume for the detection of pulmonary embolism: a comparison with standard CTPA.
     Eur Radiol. 2023 Sep 1. doi: 10.1007/s00330-023-10101.
     PubMed    
     Abstract available
     
     

145. DING W, Gu Y, Wang H, Wu H, et al
     Prenatal MRI assessment of mediastinal shift angle as a feasible and effective risk stratification tool in isolated right-sided congenital diaphragmatic hernia.
     Eur Radiol. 2024;34:1524-1533.
     PubMed    
     Abstract available
     
     

146. SESHADRI N, Kim LY, McGrath-Morrow SA, Collaco JM, et al
     Human Milk Cessation in the NICU in Infants with Bronchopulmonary Dysplasia.
     Am J Perinatol. 2021 Nov 9. doi: 10.1055/a-1692-0796.
     PubMed    
     Abstract available
     
     

147. BARTAKKE AA, Saez de Ibarra Sanchez JI
     Successful perioperative management of a primary pulmonary arterial angiosarcoma: case report.
     Braz J Anesthesiol. 2024;74:744186.
     PubMed    
     Abstract available
     
     

148. JOYE S, Bhattacharya S, Kharrat A, Jasani B, et al
     Shape of Pulmonary Artery Doppler Flow Profile and Right Ventricular Hemodynamics in Neonates.
     J Pediatr. 2023 Dec 3:113864. doi: 10.1016/j.jpeds.2023.113864.
     PubMed    
     Abstract available
     
     

149. PHILIP N, Yun X, Pi H, Murray S, et al
     Fatty acid metabolism promotes TRPV4 activity in lung microvascular endothelial cells in pulmonary arterial hypertension.
     Am J Physiol Lung Cell Mol Physiol. 2024;326:L252-L265.
     PubMed    
     Abstract available
     
     

150. NAEIJE R, Tonelli AR
     Pulmonary Artery Wedge Pressure in the Diagnosis of Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2024;209:242-244.
     PubMed    
     
     
     

151. HARDER EM, Divo MJ, Washko GR, Leopold JA, et al
     Implications of Mean Pulmonary Arterial Wedge Pressure Trajectories in Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2024;209:316-324.
     PubMed    
     Abstract available
     
     

152. BALASUBRAMANIAN A, Larive B, Horn EM, DuBrock HM, et al
     Health-Related Quality of Life Across the Spectrum of Pulmonary Hypertension.
     Chest. 2024 Feb 12:S0012-3692(24)00155-7. doi: 10.1016/j.chest.2024.
     PubMed    
     Abstract available
     
     

153. FAUVEL C, White RJ, Vanderpool RR, Badagliacca R, et al
     Risk Stratification in Pulmonary Arterial Hypertension: Perhaps Simple Is Not Best?
     Chest. 2024;165:431-436.
     PubMed    
     
     
     

154. MOORE J, Remy J, Altschul E, Chusid J, et al
     Thoracic Applications of Spectral CT Scan.
     Chest. 2024;165:417-430.
     PubMed    
     Abstract available
     
     

155. MURUGESAN P, Zhang Y, Huang Y, Chengong Zong N, et al
     Reversal of Pulmonary Hypertension in a Human-Like Model: Therapeutic Targeting of Endothelial DHFR.
     Circ Res. 2024 Feb 1. doi: 10.1161/CIRCRESAHA.123.323090.
     PubMed    
     Abstract available
     
     

156. LUO Y, Qi X, Zhang Z, Zhang J, et al
     Inactivation of Malic Enzyme 1 in Endothelial Cells Alleviates Pulmonary Hypertension.
     Circulation. 2024 Feb 5. doi: 10.1161/CIRCULATIONAHA.123.067579.
     PubMed    
     Abstract available
     
     

157. FEI Q, Pan J, Zhang F, Lin Y, et al
     Comparison of Different Treatments of Persistent Pulmonary Hypertension of the Newborn: A Systematic Review and Network Meta-Analysis.
     Crit Care Med. 2024 Feb 16. doi: 10.1097/CCM.0000000000006227.
     PubMed    
     Abstract available
     
     

158. DURRINGTON C, Hurdman JA, Elliot CA, Maclean R, et al
     Systematic pulmonary embolism follow-up increases diagnostic rates of chronic thromboembolic pulmonary hypertension and identifies less severe disease: results from the ASPIRE Registry.
     Eur Respir J. 2024 Feb 1:2300846. doi: 10.1183/13993003.00846-2023.
     PubMed    
     Abstract available
     
     

159. GERGES C, Montani D, Humbert M, Lang IM, et al
     Hemodynamic phenotypes of pulmonary hypertension associated with left heart disease: a moving target.
     Eur Respir J. 2024 Feb 15:2302280. doi: 10.1183/13993003.02280-2023.
     PubMed    
     
     
     

160. HIRATA Y, Tsuji T, Kotoku J, Sata M, et al
     Echocardiographic artificial intelligence for pulmonary hypertension classification.
     Heart. 2024 Jan 30:heartjnl-2023-323320. doi: 10.1136/heartjnl-2023-323320.
     PubMed    
     Abstract available
     
     

161. CRISAN S, Baghina RM, Luca SA, Cozlac AR, et al
     Comprehensive imaging in patients with suspected pulmonary arterial hypertension.
     Heart. 2023 Jul 18:heartjnl-2022-322182. doi: 10.1136/heartjnl-2022-322182.
     PubMed    
     Abstract available
     
     

162. SINGH N, Mehta S
     Artificial intelligence to improve the diagnosis of pulmonary hypertension: promises and pitfalls.
     Heart. 2024 Feb 15:heartjnl-2023-323693. doi: 10.1136/heartjnl-2023-323693.
     PubMed    
     
     
     

163. LUNA-LOPEZ R, Segura de la Cal T, Sarnago Cebada F, Martin de Miguel I, et al
     Triple vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease.
     Heart. 2024;110:346-352.
     PubMed    
     Abstract available
     
     

164. D'ALTO M, Bassareo PP
     Raising the bar: triple therapy for pulmonary arterial hypertension associated with congenital heart disease.
     Heart. 2024;110:309-310.
     PubMed    
     
     
     

165. UBBEN T, Frerker C, Fujita B, Rosenkranz S, et al
     Association of pulmonary hypertension with the outcome in patients undergoing edge-to-edge mitral valve repair.
     Heart. 2024 Feb 22:heartjnl-2023-323473. doi: 10.1136/heartjnl-2023-323473.
     PubMed    
     Abstract available
     
     

166. LOWERY MM, Hill NS, Wang L, Rosenzweig EB, et al
     Sleep-Related Hypoxia, Right Ventricular Dysfunction, and Survival in Patients With Group 1 Pulmonary Arterial Hypertension.
     J Am Coll Cardiol. 2023;82:1989-2005.
     PubMed    
     Abstract available
     
     

167. DESJARDIN JT, Kime N, Kolaitis NA, Kronmal RA, et al
     Investigating the "sex paradox" in pulmonary arterial hypertension: results from the Pulmonary Hypertension Association Registry (PHAR).
     J Heart Lung Transplant. 2024 Feb 13:S1053-2498(24)00044.
     PubMed    
     Abstract available
     
     

168. ZEDER K, Marsh LM, Avian A, Brcic L, et al
     Compartment-specific remodeling patterns in end-stage chronic obstructive pulmonary disease with and without severe pulmonary hypertension.
     J Heart Lung Transplant. 2024 Feb 19:S1053-2498(24)01087.
     PubMed    
     Abstract available
     
     

169. RAKO ZA, Yogeswaran A, Yildiz S, Weidemann P, et al
     Liver stiffness is associated with right heart dysfunction, cardiohepatic syndrome, and prognosis in pulmonary hypertension.
     J Heart Lung Transplant. 2024 Feb 17:S1053-2498(24)00056.
     PubMed    
     Abstract available
     
     

170. HICKS TD, Cameron J, Wang S, Ashrafi A, et al
     Assessing the role of tracheostomy placement in bronchopulmonary dysplasia with pulmonary hypertension.
     J Perinatol. 2024 Feb 5. doi: 10.1038/s41372-024-01881.
     PubMed    
     Abstract available
     
     

171. PICCARI L, Wort SJ
     Use of inhaled treprostinil in patients with interstitial lung disease and pulmonary hypertension: to boldly go where no other pulmonary vasodilator has gone before?
     Thorax. 2024 Feb 2:thorax-2023-221167. doi: 10.1136/thorax-2023-221167.
     PubMed